Revenue expansion and profit gains suggest continued operational stability, though earnings remain modest in absolute terms.
Key Highlights
- Revenue increased 5.6% to $567K for the full-year FY2019 period
- Net profit rose 3.2% to $16K year-on-year
- EBITDA reached $37K, with EBIT of $29K
- Dividend per share of 3.5 cents declared for the period
- Governance score of 62.07/100 indicates "Good" standards
Financial Performance
Green Cross Health Limited's FY2019 full-year results indicate modest but positive financial momentum. Revenue expanded to $567K, representing a 5.6% increase from the prior corresponding period, based on available data. This suggests the company maintained its operational trajectory despite operating in the competitive healthcare sector.
Net profit of $16K reflects a 3.2% year-on-year increase, indicating that profit growth lagged slightly behind revenue expansion. EBITDA of $37K and EBIT of $29K suggest the company generated positive operational earnings before interest, tax, depreciation and amortisation, though absolute profit levels remain constrained. The relationship between these metrics indicates operating leverage within the business, with EBITDA exceeding net profit by a material margin.
Earnings Analysis
The divergence between revenue growth (5.6%) and net profit growth (3.2%) appears to suggest that margin compression or increased operating costs may have absorbed a portion of the revenue gains during FY2019. This pattern indicates the company faced headwinds in converting top-line growth into proportional bottom-line expansion, a dynamic worth monitoring in subsequent reporting periods.
Dividend Update
Green Cross Health declared a dividend per share of 3.5 cents for FY2019. The company's recent dividend history indicates a special dividend of 28.0 cents alongside a final dividend of 4.5 cents and an interim dividend of 3.5 cents, suggesting variable capital distribution policies across different periods.
What This Means
The results indicate a healthcare business operating with positive but modest profitability metrics. The company's governance score of 62.07/100 suggests reasonable standards of corporate governance and disclosure. Investors and stakeholders should note that absolute profit levels remain small relative to revenue, which may reflect the company's scale or operational structure within the healthcare sector. The modest earnings base underscores the importance of monitoring operational efficiency and cost management in future periods.
---
This article was generated from structured NZX data by NZXplorer's automated reporting system. It is provided for informational purposes only and does not constitute financial advice. Data sourced from NZX company announcements and public filings. Always consult a licensed financial adviser before making investment decisions.